Literature DB >> 10623720

The VP5 domain of VP4 can mediate attachment of rotaviruses to cells.

S Zárate1, R Espinosa, P Romero, E Méndez, C F Arias, S López.   

Abstract

Some animal rotaviruses require the presence of sialic acid (SA) on the cell surface to infect the cell. We have isolated variants of rhesus rotavirus (RRV) whose infectivity no longer depends on SA. Both the SA-dependent and -independent interactions of these viruses with the cell are mediated by the virus spike protein VP4, which is cleaved by trypsin into two domains, VP5 and VP8. In this work we have compared the binding characteristics of wild-type RRV and its variant nar3 to MA104 cells. In a direct nonradioactive binding assay, both viruses bound to the cells in a saturable and specific manner. When neutralizing monoclonal antibodies directed to both the VP8 and VP5 domains of VP4 were used to block virus binding, antibodies to VP8 blocked the cell attachment of wild-type RRV but not that of the variant nar3. Conversely, an antibody to VP5 inhibited the binding of nar3 but not that of RRV. These results suggest that while RRV binds to the cell through VP8, the variant does so through the VP5 domain of VP4. This observation was further sustained by the fact that recombinant VP8 and VP5 proteins, produced in bacteria as fusion products with glutathione S-transferase, were found to bind to MA104 cells in a specific and saturable manner and, when preincubated with the cell, were capable of inhibiting the binding of wild-type and variant viruses, respectively. In addition, the VP5 and VP8 recombinant proteins inhibited the infectivity of nar3 and RRV, respectively, confirming the results obtained in the binding assays. Interestingly, when the infectivity assay was performed on neuraminidase-treated cells, the VP5 fusion protein was also found to inhibit the infectivity of RRV, suggesting that RRV could bind to the cell through two sequential steps mediated by the interaction of VP8 and VP5 with SA-containing and SA-independent cell surface receptors, respectively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623720      PMCID: PMC111578          DOI: 10.1128/jvi.74.2.593-599.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin.

Authors:  L Fiore; H B Greenberg; E R Mackow
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

2.  Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.

Authors:  F M Ruggeri; H B Greenberg
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

3.  DNA amplification-restricted transcription-translation: rapid analysis of rhesus rotavirus neutralization sites.

Authors:  E R Mackow; M Y Yamanaka; M N Dang; H B Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 4.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

5.  The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region.

Authors:  E R Mackow; R D Shaw; S M Matsui; P T Vo; M N Dang; H B Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

6.  Primary structure of the cleavage site associated with trypsin enhancement of rotavirus SA11 infectivity.

Authors:  S López; C F Arias; J R Bell; J H Strauss; R T Espejo
Journal:  Virology       Date:  1985-07-15       Impact factor: 3.616

7.  Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell adsorption.

Authors:  K Fukudome; O Yoshie; T Konno
Journal:  Virology       Date:  1989-09       Impact factor: 3.616

8.  The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus.

Authors:  M Lizano; S López; C F Arias
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  Role of VP3 in human rotavirus internalization after target cell attachment via VP7.

Authors:  N Fukuhara; O Yoshie; S Kitaoka; T Konno
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

10.  Characterization of binding of simian rotavirus SA-11 to cultured epithelial cells.

Authors:  D J Keljo; A K Smith
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 Mar-Apr       Impact factor: 2.839

View more
  27 in total

1.  Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains.

Authors:  M Ciarlet; S E Crawford; M K Estes
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core.

Authors:  P R Dormitzer; H B Greenberg; S C Harrison
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin.

Authors:  Max Ciarlet; Juan E Ludert; Miren Iturriza-Gómara; Ferdinando Liprandi; James J Gray; Ulrich Desselberger; Mary K Estes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Heat shock cognate protein 70 is involved in rotavirus cell entry.

Authors:  Carlos A Guerrero; Daniela Bouyssounade; Selene Zárate; Pavel Isa; Tomás López; Rafaela Espinosa; Pedro Romero; Ernesto Méndez; Susana López; Carlos F Arias
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  VP7 mediates the interaction of rotaviruses with integrin alphavbeta3 through a novel integrin-binding site.

Authors:  Selene Zárate; Pedro Romero; Rafaela Espinosa; Carlos F Arias; Susana López
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  Solar and temperature treatments affect the ability of human rotavirus wa to bind to host cells and synthesize viral RNA.

Authors:  Ofelia C Romero-Maraccini; Joanna L Shisler; Thanh H Nguyen
Journal:  Appl Environ Microbiol       Date:  2015-04-10       Impact factor: 4.792

7.  Identification of Equine Lactadherin-derived Peptides That Inhibit Rotavirus Infection via Integrin Receptor Competition.

Authors:  Andrea Civra; Maria Gabriella Giuffrida; Manuela Donalisio; Lorenzo Napolitano; Yoshikazu Takada; Barbara S Coulson; Amedeo Conti; David Lembo
Journal:  J Biol Chem       Date:  2015-03-26       Impact factor: 5.157

8.  Design and Construction of Chimeric VP8-S2 Antigen for Bovine Rotavirus and Bovine Coronavirus.

Authors:  Khadijeh Nasiri; Mohammadreza Nassiri; Mojtaba Tahmoorespur; Alireza Haghparast; Saeed Zibaee
Journal:  Adv Pharm Bull       Date:  2016-03-17

9.  pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization.

Authors:  Joseph B Pesavento; Sue E Crawford; Ed Roberts; Mary K Estes; B V Venkataram Prasad
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

10.  The peptide-binding and ATPase domains of recombinant hsc70 are required to interact with rotavirus and reduce its infectivity.

Authors:  Jimena Pérez-Vargas; Pedro Romero; Susana López; Carlos F Arias
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.